Topical fentanyl in a randomized, double-blind study in patients with corneal damage.

TY - JOUR

T1 - Topical fentanyl in a randomized, double-blind study in patients with corneal damage.

AU - Zöllner, Christian

AU - Mousa, Shaaban

AU - Klinger, Astrid

AU - Förster, Michael

AU - Schäfer, Michael

PY - 2008

Y1 - 2008

N2 - OBJECTIVES: Corneal damage causes severe pain. This study investigated whether peripheral opioid receptors are present in the human cornea and assessed the efficacy of topical fentanyl in patients with corneal erosion. METHODS: Immunohistochemical staining experiments were performed to examine the presence of both mu and delta-receptors on peripheral nerve fibers within human corneal tissue. In a randomized, double-blind clinical trial dexpanthenol (n=20) or dexpanthenol plus 10 microg fentanyl (n=20) were topically applied every 4 hours to the eye of patients with a surgical intervention of corneal damage and subjective pain intensity was determined by a numerical rating scale. RESULTS: Immunohistochemical staining identified peripheral nerve fibers in human cornea expressing both mu and delta-opioid receptors. In patients with corneal damage the ophthalmic intervention in local anesthesia decreased the subjective pain intensity significantly. At 4-hour intervals after the ophthalmic intervention, moderate pain intensity levels were not altered by the application of dexpanthenol with or without fentanyl. At 24 hours pain intensity dropped significantly, most likely owing to a natural decrease in pain, because the erosion was almost healed. DISCUSSION: Both mu and delta-receptors are localized on nerve fibers within the cornea, which are accessible for topical opioid treatment. However, our formulation and dose of topical fentanyl in combination with dexpanthenol did not show any benefit in relieving pain from corneal erosion. Future studies are planned to determine the optimal protocol and dose of topical opioid treatment.

AB - OBJECTIVES: Corneal damage causes severe pain. This study investigated whether peripheral opioid receptors are present in the human cornea and assessed the efficacy of topical fentanyl in patients with corneal erosion. METHODS: Immunohistochemical staining experiments were performed to examine the presence of both mu and delta-receptors on peripheral nerve fibers within human corneal tissue. In a randomized, double-blind clinical trial dexpanthenol (n=20) or dexpanthenol plus 10 microg fentanyl (n=20) were topically applied every 4 hours to the eye of patients with a surgical intervention of corneal damage and subjective pain intensity was determined by a numerical rating scale. RESULTS: Immunohistochemical staining identified peripheral nerve fibers in human cornea expressing both mu and delta-opioid receptors. In patients with corneal damage the ophthalmic intervention in local anesthesia decreased the subjective pain intensity significantly. At 4-hour intervals after the ophthalmic intervention, moderate pain intensity levels were not altered by the application of dexpanthenol with or without fentanyl. At 24 hours pain intensity dropped significantly, most likely owing to a natural decrease in pain, because the erosion was almost healed. DISCUSSION: Both mu and delta-receptors are localized on nerve fibers within the cornea, which are accessible for topical opioid treatment. However, our formulation and dose of topical fentanyl in combination with dexpanthenol did not show any benefit in relieving pain from corneal erosion. Future studies are planned to determine the optimal protocol and dose of topical opioid treatment.

M3 - SCORING: Zeitschriftenaufsatz

VL - 24

SP - 690

EP - 696

JO - CLIN J PAIN

JF - CLIN J PAIN

SN - 0749-8047

IS - 8

M1 - 8

ER -